Yang et al. have described a fibroblast growth factor receptor 1 and 2 (fgfr1, fgfr2) knock out mouse model that develops skin lesions similar to those in patients with AD, particularly with regard to the inflammatory infiltrate and the epidermal thickening [57]. Here, FGFR2 is linked to Alzheimer disease.